Experimental Pill Shows Promise in Treating Advanced Pancreatic Cancer
A new experimental pill called daraxonrasib has shown significant improvement in survival time for patients with advanced pancreatic cancer, nearly doubling median survival compared to chemotherapy. The drug targets a mutated protein responsible for tumor growth and was well-tolerated by patients.
Topics: clinical trial results new drug development pancreatic cancer